Real-world healthcare resource utilization and total cost of care among US Medicare patients with chronic lymphocytic leukemia receiving first-line ibrutinib vs chemoimmunotherapy Meeting Abstract


Authors: Huang, Q.; Emond, B.; Lafeuille, M. H.; Gupta, D.; Lefebvre, P.; Sundaram, M.; Mato, A.
Abstract Title: Real-world healthcare resource utilization and total cost of care among US Medicare patients with chronic lymphocytic leukemia receiving first-line ibrutinib vs chemoimmunotherapy
Meeting Title: ISPOR 2020 HEOR: Advancing Evidence to Action
Journal Title: Value in Health
Volume: 23
Issue: Suppl. 1
Meeting Dates: 2020 May 18-20
Meeting Location: Virtual
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2020-01-01
Start Page: S44
End Page: S45
Language: English
ACCESSION: WOS:000535812700196
PROVIDER: wos
DOI: 10.1016/j.jval.2020.04.1614
Notes: Meeting Abstract: PCN124 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato